Table 1.

Baseline subject characteristics by treatment group

CharacteristicsCholecalciferol (n = 22)Doxercalciferol (n = 25)P
CKD, n0.51
    Stage 31216
    Stage 41019
Gender, n0.20
    Female129
    Male1016
Race, n0.20
    African American16612
    White613
Cause of CKD, diabetes/hypertension/other causes, %36/40/2450/31/18
Age, yr62 ± 1065 ± 100.31
Years of CKD4.2 ± 2.63.9 ± 2.70.73
GFR (MDRD)29.6 ± 7.436.4 ± 10.70.02
Creatinine, mg/dl2.56 ± 0.832.19 ± 0.500.08
BMI34.8 ± 5.935.9 ± 8.60.60
Albumin, mg/dl4.7 ± 0.54.7 ± 0.50.85
  • BMI, body mass index.